FDA approves new blood test to detect colon cancer

The Food and Drug Administration approved on Monday 'Guardian Health'The blood test, called Shield, is used to detect colon cancer.…

A poor earnings report from a competitor is good news for Abbott Labs

Every weekday, the CNBC Investment Club with Jim Cramer hosts a live “Morning Meeting” broadcast at 10:20 a.m. ET. Here’s…

Fund manager of names in weight loss and biotechnology

Weight-loss drugs have sparked investor interest and shaken up other sectors over the past year. Novo Nordisk and Eli Lilly…